rs3815901
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000208.4(INSR):c.1611-126T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.452 in 1,020,650 control chromosomes in the GnomAD database, including 108,120 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.50 ( 19646 hom., cov: 32)
Exomes 𝑓: 0.44 ( 88474 hom. )
Consequence
INSR
NM_000208.4 intron
NM_000208.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.403
Publications
4 publications found
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
- insulin-resistance syndrome type AInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- Donohue syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- hyperinsulinism due to INSR deficiencyInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
- Rabson-Mendenhall syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 19-7166530-A-G is Benign according to our data. Variant chr19-7166530-A-G is described in ClinVar as Benign. ClinVar VariationId is 1231520.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.639 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| INSR | NM_000208.4 | c.1611-126T>C | intron_variant | Intron 7 of 21 | ENST00000302850.10 | NP_000199.2 | ||
| INSR | NM_001079817.3 | c.1611-126T>C | intron_variant | Intron 7 of 20 | NP_001073285.1 | |||
| INSR | XM_011527988.3 | c.1611-126T>C | intron_variant | Intron 7 of 21 | XP_011526290.2 | |||
| INSR | XM_011527989.4 | c.1611-126T>C | intron_variant | Intron 7 of 20 | XP_011526291.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| INSR | ENST00000302850.10 | c.1611-126T>C | intron_variant | Intron 7 of 21 | 1 | NM_000208.4 | ENSP00000303830.4 | |||
| INSR | ENST00000341500.9 | c.1611-126T>C | intron_variant | Intron 7 of 20 | 1 | ENSP00000342838.4 | ||||
| INSR | ENST00000598216.1 | n.1586-126T>C | intron_variant | Intron 7 of 9 | 1 | |||||
| INSR | ENST00000600492.1 | c.12-126T>C | intron_variant | Intron 1 of 3 | 5 | ENSP00000473170.1 |
Frequencies
GnomAD3 genomes AF: 0.499 AC: 75831AN: 151884Hom.: 19601 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
75831
AN:
151884
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.443 AC: 385118AN: 868648Hom.: 88474 AF XY: 0.447 AC XY: 199564AN XY: 446248 show subpopulations
GnomAD4 exome
AF:
AC:
385118
AN:
868648
Hom.:
AF XY:
AC XY:
199564
AN XY:
446248
show subpopulations
African (AFR)
AF:
AC:
13562
AN:
21066
American (AMR)
AF:
AC:
13102
AN:
32782
Ashkenazi Jewish (ASJ)
AF:
AC:
11660
AN:
21402
East Asian (EAS)
AF:
AC:
9544
AN:
33286
South Asian (SAS)
AF:
AC:
36366
AN:
67026
European-Finnish (FIN)
AF:
AC:
15720
AN:
35068
Middle Eastern (MID)
AF:
AC:
1944
AN:
3626
European-Non Finnish (NFE)
AF:
AC:
264338
AN:
613764
Other (OTH)
AF:
AC:
18882
AN:
40628
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
10394
20789
31183
41578
51972
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6030
12060
18090
24120
30150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.499 AC: 75920AN: 152002Hom.: 19646 Cov.: 32 AF XY: 0.499 AC XY: 37106AN XY: 74298 show subpopulations
GnomAD4 genome
AF:
AC:
75920
AN:
152002
Hom.:
Cov.:
32
AF XY:
AC XY:
37106
AN XY:
74298
show subpopulations
African (AFR)
AF:
AC:
26764
AN:
41466
American (AMR)
AF:
AC:
6520
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
AC:
1862
AN:
3468
East Asian (EAS)
AF:
AC:
1669
AN:
5172
South Asian (SAS)
AF:
AC:
2651
AN:
4816
European-Finnish (FIN)
AF:
AC:
4921
AN:
10568
Middle Eastern (MID)
AF:
AC:
151
AN:
292
European-Non Finnish (NFE)
AF:
AC:
29709
AN:
67950
Other (OTH)
AF:
AC:
1130
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1913
3826
5740
7653
9566
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1803
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.